Company Number: SO307686

Analysis Date: 2025-07-07 22:54 UTC

Financial Health Assessment for RYSE CIV GP LLP

1. Financial Health Score: Grade D (Dormant Status) Explanation: The company is newly incorporated (December 2022) and classified as dormant with no trading activity or financial transactions during the reporting period to 30 September 2023. This means there are no operational financial metrics to analyze. While a dormant status is not inherently negative, it indicates the company has not yet begun active business operations or generated revenue, which is a key "vital sign" of business health.

2. Key Vital Signs:

• Trading Activity: None. The company reported zero turnover, zero profit, and no members’ remuneration or drawings during the period.
• Assets & Liabilities: Net assets and members’ interests are zero, indicating no capital invested or accumulated profits/losses.
• Cash Flow: No cash inflows or outflows were recorded, signifying no operational, investing, or financing activity.
• Filing & Compliance: Accounts and confirmation statements are filed on time and up to date, showing good compliance health.
• Control & Governance: Controlled by two designated members (RYSE Health Ltd and RYSE Healthcare Ltd) with shared voting rights and interests, providing a stable governance framework.

3. Diagnosis:

The company currently exhibits the "symptom" of dormancy, meaning it has not commenced active trading or financial operations. This is typical for a newly established entity that may be in a pre-operational phase, setting up structures or awaiting capital injection or business opportunities. The lack of financial activity precludes assessment of profitability, liquidity, or solvency metrics, which are essential "vital signs" of financial health.

From a financial wellness perspective, the company is in a neutral state: not showing distress but also not demonstrating growth or operational health. The going concern assumption is supported by the members, indicating confidence that the LLP will continue operations in the foreseeable future.

4. Recommendations:

• Initiate Operational Activities: To move from dormancy to a healthy operational status, the company should start trading, generating revenue, and managing expenses.
• Capital Planning: Consider capital contributions or financing arrangements to support initial business activities and working capital needs.
• Financial Monitoring: Once operational, implement rigorous financial tracking of cash flow, profitability, and balance sheet strength to detect early "symptoms" of financial distress.
• Compliance Maintenance: Continue good practice filing timely accounts and confirmation statements to avoid penalties and maintain regulatory health.
• Strategic Planning: Develop a clear business plan with milestones, budgeting, and risk assessment to guide the transition from dormancy to active trading and growth.

The company should view this dormant period as a preparatory stage. With appropriate strategic and financial steps, RYSE CIV GP LLP can establish a "healthy cash flow" pattern and positive balance sheet indicators in future reporting periods.